Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Bay

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Neuropediatrics|November 24, 1999
Physical map of the region surrounding the ataxia-telangiectasia gene on human chromosome 11q22-23N S Udar, S Xu, J O Bay, et al.
Bone Marrow Transplantation|December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)P Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Pathologie-Biologie|June 30, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]D Blaise, S Nguyen, J-O Bay, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma groupA T Falk, L Moureau-Zabotto, M Ouali, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)P Pautier, N Penel, I Ray-Coquard, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Neuropediatrics|November 24, 1999
Physical map of the region surrounding the ataxia-telangiectasia gene on human chromosome 11q22-23N S Udar, S Xu, J O Bay, et al.
Bone Marrow Transplantation|December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)P Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt, M Bregni, M Remberger, et al.
Pathologie-Biologie|June 30, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]D Blaise, S Nguyen, J-O Bay, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma groupA T Falk, L Moureau-Zabotto, M Ouali, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)P Pautier, N Penel, I Ray-Coquard, et al.
Pageof 8